Visionary Holdings: Generative AI Leads the Efficiency Revolution, Reshaping the Future of FinTech and Biotechnology
Visionary Holdings (GV) has demonstrated significant achievements in implementing generative AI across FinTech and biotechnology sectors. The company's AI solutions have delivered notable improvements in their digital asset trading platform, including a 40% reduction in transaction delays and a 97.5% fraud detection rate.
In their FinTech operations, AI implementation has reduced labor costs by 40% while increasing customer satisfaction to 94.2%. Their biotechnology division has achieved a 98.7% sensitivity rate in AI-driven cervical cancer E7 protein detection, earning FDA certification.
The company's AI system operates on a four-layer architecture: Intelligent Perception, Cognitive Decision, Generative Execution, and Autonomous Evolution, enabling comprehensive solutions across financial and medical applications. According to IDC, AI is projected to contribute $19.9 trillion to the global economy by 2030, representing 3.5% of global GDP.
Visionary Holdings (GV) ha dimostrato risultati significativi nell'implementazione dell'IA generativa nei settori FinTech e biotecnologico. Le soluzioni AI dell'azienda hanno portato a notevoli miglioramenti nella loro piattaforma di trading di asset digitali, tra cui una riduzione del 40% nei ritardi delle transazioni e un tasso di rilevamento delle frodi del 97,5%.
Nelle loro operazioni FinTech, l'implementazione dell'IA ha ridotto i costi lavorativi del 40% aumentando la soddisfazione del cliente al 94,2%. La loro divisione biotecnologica ha raggiunto un tasso di sensibilità del 98,7% nella rilevazione della proteina E7 del cancro cervicale tramite IA, ottenendo la certificazione FDA.
Il sistema AI dell'azienda opera su un'architettura a quattro livelli: Percezione Intelligente, Decisione Cognitiva, Esecuzione Generativa ed Evoluzione Autonoma, consentendo soluzioni complete in ambito finanziario e medico. Secondo IDC, si prevede che l'IA contribuirà con 19,9 trilioni di dollari all'economia globale entro il 2030, rappresentando il 3,5% del PIL globale.
Visionary Holdings (GV) ha demostrado logros significativos en la implementación de IA generativa en los sectores de FinTech y biotecnología. Las soluciones de IA de la empresa han proporcionado mejoras notables en su plataforma de comercio de activos digitales, incluyendo una reducción del 40% en los retrasos de transacciones y una tasa de detección de fraude del 97,5%.
En sus operaciones de FinTech, la implementación de IA ha reducido los costos laborales en un 40% mientras que la satisfacción del cliente ha aumentado al 94,2%. Su división de biotecnología ha logrado una tasa de sensibilidad del 98,7% en la detección de la proteína E7 del cáncer cervical impulsada por IA, obteniendo la certificación de la FDA.
El sistema de IA de la empresa opera en una arquitectura de cuatro capas: Percepción Inteligente, Decisión Cognitiva, Ejecución Generativa y Evolución Autónoma, lo que permite soluciones integrales en aplicaciones financieras y médicas. Según IDC, se proyecta que la IA contribuirá con 19,9 billones de dólares a la economía global para 2030, representando el 3,5% del PIB global.
비전홀딩스(GV)는 핀테크 및 생명공학 분야에서 생성적 AI를 구현하여 상당한 성과를 보여주었습니다. 회사의 AI 솔루션은 디지털 자산 거래 플랫폼에서 거래 지연을 40% 줄이고 97.5%의 사기 탐지율을 달성하는 등 주목할 만한 개선을 가져왔습니다.
핀테크 운영에서 AI 구현은 인건비를 40% 줄이는 동시에 고객 만족도를 94.2%로 증가시켰습니다. 생명공학 부문은 AI 기반 자궁경부암 E7 단백질 탐지에서 98.7%의 민감도 비율을 달성하여 FDA 인증을 받았습니다.
회사의 AI 시스템은 지능적 인식, 인지적 결정, 생성적 실행, 자율적 진화의 네 가지 계층 아키텍처로 운영되며, 금융 및 의료 분야 전반에 걸쳐 포괄적인 솔루션을 제공합니다. IDC에 따르면 AI는 2030년까지 세계 경제에 19.9조 달러를 기여할 것으로 예상되며, 이는 세계 GDP의 3.5%를 차지합니다.
Visionary Holdings (GV) a démontré des réalisations significatives dans la mise en œuvre de l'IA générative dans les secteurs de la FinTech et de la biotechnologie. Les solutions d'IA de l'entreprise ont entraîné des améliorations notables sur leur plateforme de trading d'actifs numériques, y compris une réduction de 40% des délais de transaction et un taux de détection de fraude de 97,5%.
Dans leurs opérations FinTech, l'implémentation de l'IA a réduit les coûts de main-d'œuvre de 40% tout en augmentant la satisfaction client à 94,2%. Leur division biotechnologique a atteint un taux de sensibilité de 98,7% dans la détection de la protéine E7 du cancer du col de l'utérus grâce à l'IA, obtenant la certification de la FDA.
Le système d'IA de l'entreprise fonctionne sur une architecture à quatre niveaux : Perception Intelligente, Décision Cognitive, Exécution Générative et Évolution Autonome, permettant des solutions complètes dans les applications financières et médicales. Selon IDC, l'IA devrait contribuer 19,9 billions de dollars à l'économie mondiale d'ici 2030, représentant 3,5% du PIB mondial.
Visionary Holdings (GV) hat bedeutende Erfolge bei der Implementierung von generativer KI in den Bereichen FinTech und Biotechnologie erzielt. Die KI-Lösungen des Unternehmens haben bemerkenswerte Verbesserungen auf ihrer digitalen Handelsplattform für Vermögenswerte gebracht, darunter eine Reduzierung der Transaktionsverzögerungen um 40% und eine Betrugserkennungsrate von 97,5%.
In ihren FinTech-Operationen hat die Implementierung von KI die Arbeitskosten um 40% gesenkt und die Kundenzufriedenheit auf 94,2% erhöht. Ihre Biotechnologie-Abteilung hat eine Empfindlichkeitsrate von 98,7% bei der KI-gestützten Erkennung des E7-Proteins von Gebärmutterhalskrebs erreicht und die FDA-Zertifizierung erhalten.
Das KI-System des Unternehmens arbeitet auf einer vierstufigen Architektur: Intelligente Wahrnehmung, Kognitive Entscheidung, Generative Ausführung und Autonome Evolution, die umfassende Lösungen in finanziellen und medizinischen Anwendungen ermöglicht. Laut IDC wird erwartet, dass die KI bis 2030 19,9 Billionen Dollar zur globalen Wirtschaft beitragen wird, was 3,5% des globalen BIP entspricht.
- 40% reduction in transaction processing delays
- 97.5% fraud detection rate in financial operations
- 40% reduction in customer service labor costs
- 94.2% customer satisfaction rate
- 98.7% sensitivity rate in cancer detection with FDA certification
- None.
In the FinTech and digital currency sectors, traditional operational models face numerous challenges, particularly in transaction processing delays and risk control compliance. The high volatility of the digital currency market makes it difficult for traditional matching engines to handle massive orders during peak trading periods, causing delays that severely impact investor decision-making. At the same time, increasingly stringent global regulatory policies require FinTech companies to monitor abnormal transactions in real time, a task for which traditional risk control systems are often inadequate.
Visionary Holdings' generative AI technology has successfully addressed these challenges. On its digital asset trading platform, AI technology has optimized the matching engine, reducing transaction delays by
The biotechnology sector also faces challenges, such as the complexity of medical data processing and the difficulty of meeting personalized healthcare needs. Traditional data analysis methods are inefficient in handling data from gene sequencing, cancer screening, and biochips, while limited medical resources hinder the development of precise, personalized treatment plans. Visionary Holdings' AI technology offers solutions to these issues. In cancer screening and genetic testing, the AI-driven analysis of biochip data for cervical cancer E7 protein detection has achieved a sensitivity rate of
Visionary Holdings' intelligent AI system employs a unique four-layer architecture to ensure efficient and intelligent management. The Intelligent Perception Layer supports multimodal inputs such as voice, text, market data, and biochip data, providing real-time investment and medical diagnostic recommendations through AI analysis. The Cognitive Decision Layer includes an intelligent risk control engine and a medical knowledge graph, enabling real-time financial risk monitoring and the generation of precise medical solutions. The Generative Execution Layer features AI trading assistants and health assistants, offering practical support services to users and patients. The Autonomous Evolution Layer uses reinforcement learning loops and human feedback optimization to continuously improve AI model accuracy, ensuring recommendations comply with regulatory and medical standards.
Looking ahead, the prospects for AI technology are vast. Visionary Holdings will continue to lead industry trends by promoting AI-driven financial compliance management, using natural language understanding to automatically adapt to financial regulations across countries and reduce compliance costs. Additionally, the company will explore the integration of quantum computing and AI to enable more complex financial modeling and medical data analysis, further enhancing predictive capabilities.
With the rapid advancement of AI technology, the global industry is expected to enter a new era of intelligence in 2024. Visionary Holdings, through its exceptional practices in generative AI, has not only achieved significant growth for its own business but also provided valuable insights for industry development, guiding the FinTech and biotechnology sectors toward a smarter and more efficient future.
For more information, please contact:
Visionary Holdings Inc.
Investor Relations Department
Email: ir@farvision.ca
View original content:https://www.prnewswire.com/news-releases/visionary-holdings-generative-ai-leads-the-efficiency-revolution-reshaping-the-future-of-fintech-and-biotechnology-302383388.html
SOURCE Visionary Holdings Inc.
FAQ
What performance improvements has GV's AI technology achieved in their digital trading platform?
How successful is GV's AI technology in cancer detection?
What cost savings has GV realized through AI implementation in customer service?
What are the four layers of GV's AI architecture system?
How much is AI expected to contribute to the global economy by 2030 according to IDC?
